Latest DEF 14A proxy statements

RYVYL Inc. will hold its 2025 Annual Meeting to vote on a reverse stock split, an increase in authorized shares, director elections, and auditor ratification, addressing Nasdaq listing compliance.

Sharps Technology, Inc. calls a Special Meeting to approve significant warrant issuances and a new director, signaling substantial dilution for existing shareholders.

NovaBay Pharmaceuticals announces a strategic pivot with a new $6.0 million investment from David E. Lazar, leading to significant shareholder dilution and a planned reverse stock split.

Exicure, Inc. announces its 2025 Annual Meeting of Stockholders to be held virtually on November 6, 2025, to vote on director elections, auditor ratification, and executive compensation.

KLA Corporation announced robust financial performance for fiscal year 2025, with significant increases in revenue, net income, and EPS, alongside proactive ESG initiatives and board enhancements.

Amcor PLC's proxy statement details a proposed 1-for-5 reverse stock split, reports strong fiscal year 2025 performance including volume growth and successful Berry Global merger integration, and outlines executive compensation and board re-elections.

Quantum Corporation has entered into a definitive agreement to restructure its outstanding term debt, exchanging approximately $52 million for senior secured convertible notes and eliminating existing financial covenants.

Independent proxy firm ISS recommends shareholders vote for Cushman & Wakefield's proposed redomiciliation to Bermuda, citing expected annual savings of US$3 million and enhanced corporate governance.

Profusa, Inc. is calling a Special Meeting of Stockholders to approve a significant convertible note financing and an increase in authorized common stock to support future growth and capital needs.

ATAI Life Sciences and Beckley Psytech announced positive Phase 2a clinical trial results for BPL-003, showing improved and sustained antidepressant effects with a two-dose regimen in treatment-resistant depression patients.

Ares Acquisition Corporation II and Kodiak Robotics, Inc. announced over $275 million in financing to support their proposed business combination, despite high shareholder redemptions and a postponed Extraordinary General Meeting.

The Marygold Companies, Inc. announced its 2025 Annual Meeting of Stockholders to be held on November 7, 2025, focusing on director elections and auditor ratification.

Big 5 Sporting Goods Corporation has rescheduled its special stockholder meeting to September 26, 2025, to vote on the proposed merger with Worldwide Sports Group Holdings LLC, while also addressing an unsolicited, deficient acquisition proposal from Party A.

BlackRock funds will hold special shareholder meetings on October 15, 2025, to vote on proposed reorganizations and mergers.

BlackRock MuniYield Michigan Quality Fund and other funds will hold a special shareholder meeting on October 15, 2025, to vote on proposed reorganizations/mergers.

Golden Matrix Group, Inc. announces its 2025 Annual Meeting of Stockholders to vote on director appointments, executive compensation, and auditor selection.

BlackRock MuniHoldings California Quality Fund and other funds will hold a special shareholder meeting on October 15, 2025, to vote on proposed reorganizations/mergers.

Aspire Biopharma Holdings, Inc. calls a Special Meeting to vote on a reverse stock split to maintain Nasdaq listing and approve the issuance of shares from convertible promissory notes.

Golden Matrix Group, Inc. announces its 2025 Annual Meeting of Stockholders to be held virtually on November 6, 2025, to vote on director elections, executive compensation, and auditor ratification.

Premier, Inc. will be acquired by an affiliate of Patient Square Capital for $28.25 per share in cash, valuing the transaction at approximately $2.6 billion.

Premier, Inc. has agreed to be acquired by an affiliate of Patient Square Capital, transitioning to private ownership to enhance financial flexibility and accelerate innovation.

Premier, Inc. announced its acquisition by Patient Square Capital for $28.25 per share, transitioning to a private company.

Premier, Inc. announced its acquisition by Patient Square Capital for $28.25 per share in cash, taking the company private.

Premier, Inc. announced an agreement to be acquired by Patient Square Capital for $28.25 per share in cash, transitioning to a private company.

ODP Corporation to be acquired by Atlas Holdings, transitioning to a private company to accelerate B2B growth initiatives.

Premier, Inc. announced an agreement to be acquired by an affiliate of Patient Square Capital for $28.25 per share in cash, transitioning to a private company.

The ODP Corporation announced its agreement to be acquired by an affiliate of Atlas Holdings, transitioning to a privately held entity.

The ODP Corporation announced its agreement to be acquired by an affiliate of Atlas Holdings, aiming to accelerate B2B growth and strengthen its market position.

The ODP Corporation announced its agreement to be acquired by an affiliate of Atlas Holdings, transitioning to a privately held entity.

The ODP Corporation announced an agreement to be acquired by an affiliate of Atlas Holdings, transitioning to a privately held company by the end of 2025.